0.018129 0.000000 0.000000 0.000000 0.018868 0.000000 0.000000 0.000000 0.012151 0.00000 0.00000 0.00000 Wendt, M.D. Rockway, T.W. Geyer, A. McClellan, W. Weitzberg, M. Zhao, X. Mantei, R. Nienaber, V.L. Stewart, K. Klinghofer, V. Giranda, V.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 55.160 53.000 82.300 C24 H24 N4 O 384.474 6-[(Z)-AMINO(IMINO)METHYL]-N-(1-ISOPROPYL-3,4-DIHYDROISOQUINOLIN-7-YL)-2-NAPHTHAMIDE 6-[N-(1-ISOPROPYL-3,4-DIHYDRO-7-ISOQUINOLINYL)CARBAMYL]-2-NAPHTHALENECARBOXAMIDINE non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Med.Chem. JMCMAR 0151 0022-2623 47 303 324 10.1021/jm0300072 14711304 Identification of Novel Binding Interactions in the Development of Potent, Selective 2-Naphthamidine Inhibitors of Urokinase. Synthesis, Structural Analysis, and SAR of N-Phenyl Amide 6-Substitution. 2004 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 160 1 IMAGE PLATE 1998-04-30 MACSCIENCE SINGLE WAVELENGTH M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU 27622.496 Urokinase-type plasminogen activator 3.4.21.73 residues 179-423 1 man polymer 384.474 6-[(Z)-AMINO(IMINO)METHYL]-N-(1-ISOPROPYL-3,4-DIHYDROISOQUINOLIN-7-YL)-2-NAPHTHAMIDE 1 syn non-polymer uPA, U-plasminogen activator no no IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVEN LILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVK LISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW IRSHT IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVEN LILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVK LISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW IRSHT A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo fall armyworm Spodoptera sample PLAU 9606 Homo sapiens 7108 Spodoptera frugiperda Baculovirus 1 2.19 43.39 software repository Initial release Version format compliance Version format compliance Refinement description 1 0 2003-09-30 1 1 2008-04-29 1 2 2011-07-13 1 3 2017-10-11 _software.classification _software.name RCSB Y RCSB 2003-03-28 REL REL 155 6-[(Z)-AMINO(IMINO)METHYL]-N-(1-ISOPROPYL-3,4-DIHYDROISOQUINOLIN-7-YL)-2-NAPHTHAMIDE 155 1 2 155 155 245 A ILE 1 n 1 ILE 1 A ILE 2 n 2 ILE 2 A GLY 3 n 3 GLY 3 A GLY 4 n 4 GLY 4 A GLU 5 n 5 GLU 5 A PHE 6 n 6 PHE 6 A THR 7 n 7 THR 7 A THR 8 n 8 THR 8 A ILE 9 n 9 ILE 9 A GLU 10 n 10 GLU 10 A ASN 11 n 11 ASN 11 A GLN 12 n 12 GLN 12 A PRO 13 n 13 PRO 13 A TRP 14 n 14 TRP 14 A PHE 15 n 15 PHE 15 A ALA 16 n 16 ALA 16 A ALA 17 n 17 ALA 17 A ILE 18 n 18 ILE 18 A TYR 19 n 19 TYR 19 A ARG 20 n 20 ARG 20 A ARG 21 n 21 ARG 21 A HIS 22 n 22 HIS 22 A ARG 23 n 23 ARG 23 A GLY 23 n 24 A GLY 23 A GLY 24 n 25 GLY 24 A SER 25 n 26 SER 25 A VAL 26 n 27 VAL 26 A THR 27 n 28 THR 27 A TYR 28 n 29 TYR 28 A VAL 29 n 30 VAL 29 A CYS 30 n 31 CYS 30 A GLY 31 n 32 GLY 31 A GLY 32 n 33 GLY 32 A SER 33 n 34 SER 33 A LEU 34 n 35 LEU 34 A MET 35 n 36 MET 35 A SER 36 n 37 SER 36 A PRO 37 n 38 PRO 37 A CYS 38 n 39 CYS 38 A TRP 39 n 40 TRP 39 A VAL 40 n 41 VAL 40 A ILE 41 n 42 ILE 41 A SER 42 n 43 SER 42 A ALA 43 n 44 ALA 43 A THR 44 n 45 THR 44 A HIS 45 n 46 HIS 45 A CYS 46 n 47 CYS 46 A PHE 47 n 48 PHE 47 A ILE 48 n 49 ILE 48 A ASP 49 n 50 ASP 49 A TYR 50 n 51 TYR 50 A PRO 51 n 52 PRO 51 A LYS 52 n 53 LYS 52 A LYS 53 n 54 LYS 53 A GLU 54 n 55 GLU 54 A ASP 55 n 56 ASP 55 A TYR 56 n 57 TYR 56 A ILE 57 n 58 ILE 57 A VAL 58 n 59 VAL 58 A TYR 59 n 60 TYR 59 A LEU 60 n 61 LEU 60 A GLY 61 n 62 GLY 61 A ARG 62 n 63 ARG 62 A SER 63 n 64 SER 63 A ARG 64 n 65 ARG 64 A LEU 65 n 66 LEU 65 A ASN 66 n 67 ASN 66 A SER 67 n 68 SER 67 A ASN 68 n 69 ASN 68 A THR 69 n 70 THR 69 A GLN 70 n 71 GLN 70 A GLY 71 n 72 GLY 71 A GLU 72 n 73 GLU 72 A MET 73 n 74 MET 73 A LYS 74 n 75 LYS 74 A PHE 75 n 76 PHE 75 A GLU 76 n 77 GLU 76 A VAL 77 n 78 VAL 77 A GLU 78 n 79 GLU 78 A ASN 79 n 80 ASN 79 A LEU 80 n 81 LEU 80 A ILE 81 n 82 ILE 81 A LEU 82 n 83 LEU 82 A HIS 83 n 84 HIS 83 A LYS 84 n 85 LYS 84 A ASP 85 n 86 ASP 85 A TYR 86 n 87 TYR 86 A SER 87 n 88 SER 87 A ALA 88 n 89 ALA 88 A ASP 89 n 90 ASP 89 A THR 90 n 91 THR 90 A LEU 91 n 92 LEU 91 A ALA 92 n 93 ALA 92 A HIS 93 n 94 HIS 93 A HIS 94 n 95 HIS 94 A ASN 95 n 96 ASN 95 A ASP 96 n 97 ASP 96 A ILE 97 n 98 ILE 97 A ALA 98 n 99 ALA 98 A LEU 99 n 100 LEU 99 A LEU 100 n 101 LEU 100 A LYS 101 n 102 LYS 101 A ILE 102 n 103 ILE 102 A ARG 103 n 104 ARG 103 A SER 104 n 105 SER 104 A LYS 105 n 106 LYS 105 A GLU 106 n 107 GLU 106 A GLY 107 n 108 GLY 107 A ARG 108 n 109 ARG 108 A CYS 109 n 110 CYS 109 A ALA 110 n 111 ALA 110 A GLN 111 n 112 GLN 111 A PRO 112 n 113 PRO 112 A SER 113 n 114 SER 113 A ARG 114 n 115 ARG 114 A THR 115 n 116 THR 115 A ILE 116 n 117 ILE 116 A GLN 117 n 118 GLN 117 A THR 118 n 119 THR 118 A ILE 119 n 120 ILE 119 A ALA 120 n 121 CYS 120 A LEU 121 n 122 LEU 121 A PRO 122 n 123 PRO 122 A SER 123 n 124 SER 123 A MET 124 n 125 MET 124 A TYR 125 n 126 TYR 125 A ASN 126 n 127 ASN 126 A ASP 127 n 128 ASP 127 A PRO 128 n 129 PRO 128 A GLN 129 n 130 GLN 129 A PHE 130 n 131 PHE 130 A GLY 131 n 132 GLY 131 A THR 132 n 133 THR 132 A SER 133 n 134 SER 133 A CYS 134 n 135 CYS 134 A GLU 135 n 136 GLU 135 A ILE 136 n 137 ILE 136 A THR 137 n 138 THR 137 A GLY 138 n 139 GLY 138 A PHE 139 n 140 PHE 139 A GLY 140 n 141 GLY 140 A LYS 141 n 142 LYS 141 A GLU 142 n 143 GLU 142 A ASN 143 n 144 ASN 143 A SER 144 n 145 SER 144 A THR 145 n 146 THR 145 A ASP 146 n 147 ASP 146 A TYR 147 n 148 TYR 147 A LEU 148 n 149 LEU 148 A TYR 149 n 150 TYR 149 A PRO 150 n 151 PRO 150 A GLU 151 n 152 GLU 151 A GLN 152 n 153 GLN 152 A LEU 153 n 154 LEU 153 A LYS 154 n 155 LYS 154 A MET 155 n 156 MET 155 A THR 156 n 157 THR 156 A VAL 157 n 158 VAL 157 A VAL 158 n 159 VAL 158 A LYS 159 n 160 LYS 159 A LEU 160 n 161 LEU 160 A ILE 161 n 162 ILE 161 A SER 162 n 163 SER 162 A HIS 163 n 164 HIS 163 A ARG 164 n 165 ARG 164 A GLU 165 n 166 GLU 165 A CYS 166 n 167 CYS 166 A GLN 167 n 168 GLN 167 A GLN 168 n 169 GLN 168 A PRO 169 n 170 PRO 169 A HIS 170 n 171 HIS 170 A TYR 171 n 172 TYR 171 A TYR 172 n 173 TYR 172 A GLY 173 n 174 GLY 173 A SER 174 n 175 SER 174 A GLU 175 n 176 GLU 175 A VAL 176 n 177 VAL 176 A THR 177 n 178 THR 177 A THR 178 n 179 THR 178 A LYS 179 n 180 LYS 179 A MET 180 n 181 MET 180 A LEU 181 n 182 LEU 181 A CYS 182 n 183 CYS 182 A ALA 183 n 184 ALA 183 A ALA 184 n 185 ALA 184 A ASP 185 n 186 ASP 185 A PRO 186 n 187 PRO 186 A GLN 187 n 188 GLN 187 A TRP 188 n 189 TRP 188 A LYS 189 n 190 LYS 189 A THR 190 n 191 THR 190 A ASP 191 n 192 ASP 191 A SER 192 n 193 SER 192 A CYS 193 n 194 CYS 193 A GLN 194 n 195 GLN 194 A GLY 195 n 196 GLY 195 A ASP 196 n 197 ASP 196 A SER 197 n 198 SER 197 A GLY 198 n 199 GLY 198 A GLY 199 n 200 GLY 199 A PRO 200 n 201 PRO 200 A LEU 201 n 202 LEU 201 A VAL 202 n 203 VAL 202 A CYS 203 n 204 CYS 203 A SER 204 n 205 SER 204 A LEU 205 n 206 LEU 205 A GLN 206 n 207 GLN 206 A GLY 207 n 208 GLY 207 A ARG 208 n 209 ARG 208 A MET 209 n 210 MET 209 A THR 210 n 211 THR 210 A LEU 211 n 212 LEU 211 A THR 212 n 213 THR 212 A GLY 213 n 214 GLY 213 A ILE 214 n 215 ILE 214 A VAL 215 n 216 VAL 215 A SER 216 n 217 SER 216 A TRP 217 n 218 TRP 217 A GLY 218 n 219 GLY 218 A ARG 219 n 220 ARG 219 A GLY 220 n 221 GLY 220 A CYS 221 n 222 CYS 221 A ALA 222 n 223 ALA 222 A LEU 223 n 224 LEU 223 A LYS 224 n 225 LYS 224 A ASP 225 n 226 ASP 225 A LYS 226 n 227 LYS 226 A PRO 227 n 228 PRO 227 A GLY 228 n 229 GLY 228 A VAL 229 n 230 VAL 229 A TYR 230 n 231 TYR 230 A THR 231 n 232 THR 231 A ARG 232 n 233 ARG 232 A VAL 233 n 234 VAL 233 A SER 234 n 235 SER 234 A HIS 235 n 236 HIS 235 A PHE 236 n 237 PHE 236 A LEU 237 n 238 LEU 237 A PRO 238 n 239 PRO 238 A TRP 239 n 240 TRP 239 A ILE 240 n 241 ILE 240 A ARG 241 n 242 ARG 241 A SER 242 n 243 SER 242 A HIS 243 n 244 HIS 243 A THR 244 n 245 THR 244 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N GLU 5 A N GLU 5 A O MET 155 A O MET 156 A O VAL 158 A O VAL 159 A N CYS 134 A N CYS 135 A N THR 137 A N THR 138 A O PRO 200 A O PRO 201 A O LEU 205 A O LEU 206 A N ARG 208 A N ARG 209 A N GLY 213 A N GLY 214 A O LEU 201 A O LEU 202 A O VAL 202 A O VAL 203 A N GLU 135 A N GLU 136 A N GLY 138 A N GLY 139 A O LYS 154 A O LYS 155 A N ILE 161 A N ILE 162 A O CYS 182 A O CYS 183 A O ALA 183 A O ALA 184 A N GLY 228 A N GLY 229 A N ARG 20 A N ARG 20 A O THR 27 A O THR 28 A O SER 36 A O SER 37 A N TRP 39 A N TRP 40 A N SER 42 A N SER 43 A O ALA 98 A O ALA 99 A O ARG 103 A O ARG 104 A N GLU 76 A N GLU 77 A N PHE 75 A N PHE 76 A O VAL 58 A O VAL 59 A O TYR 59 A O TYR 60 A N ALA 17 A N ALA 17 A O SER 87 A O SER 88 A N HIS 94 A N HIS 95 1 A SG CYS 120 A SG CYS 121 1 Y 1 14.74 2.30 115.30 130.04 A A A CA CB CG LEU LEU LEU 121 121 121 N 1 A THR 7 -109.56 -162.83 1 A PRO 13 -51.93 -6.90 1 A VAL 29 -102.78 -76.58 1 A SER 42 -134.44 -134.61 1 A PRO 51 -67.85 38.56 1 A LEU 60 -113.92 74.63 1 A ASN 68 -102.28 76.95 1 A GLN 70 -33.43 147.84 1 A LYS 84 -66.45 3.83 1 A ASP 89 -85.09 -159.83 1 A LEU 91 -143.34 -60.23 1 A ASN 95 37.84 75.24 1 A ASP 96 -113.97 66.43 1 A ARG 103 -174.75 137.91 1 A CYS 109 -101.75 -161.00 1 A ASN 126 -165.88 83.27 1 A PHE 130 -39.40 157.87 1 A THR 145 -71.48 39.01 1 A SER 162 -55.36 170.47 1 A TYR 171 -118.23 -116.81 1 A THR 177 -79.94 -167.52 1 A ASP 191 -176.37 -173.83 1 A SER 197 -46.87 154.60 1 A GLN 206 71.09 47.48 1 A SER 216 -126.16 -79.47 1 A ALA 222 70.97 37.70 1 A PRO 227 -50.46 179.98 PARAM11.WAT TOPHCSDX.PRO PARVICKI.PRO PARAM19X.PRO PARHCSDX.PRO A282155.XPRM 6.4 0.00 0.00 0.00 0.00 0.00 0.00 0.344 0.027 0.253 0.253 0.253 3.10 10.00 159 3000 3000 5.3 66.3 RANDOM 10000000.00 0.001000 1 RESTRAINED THROUGHOUT 2.0 FOURIER SYNTHESIS Engh & Huber 0.52 0.32 5.00 0.06 0.30 3.10 10.00 0 1962 29 0 1933 0.011 1.9 24.5 0.83 0.99 1.50 1.53 2.00 2.37 2.00 3.66 2.50 0.323 0.062 0.272 3.29 27 330 6 7.6 48.0 3.03 32.50 1OWJ 4264 4264 0 1 refinement X-PLOR 98.0 data collection MAR345 data scaling SCALEPACK phasing X-PLOR Urokinase-type plasminogen activator (E.C.3.4.21.73) Substituted 2-Naphthamidine Inhibitors of Urokinase 1 N N 2 N N A THR 8 A THR 8 HELX_P A GLN 12 A GLN 12 5 1 5 A ALA 43 A ALA 44 HELX_P A PHE 47 A PHE 48 5 2 5 A LYS 52 A LYS 53 HELX_P A GLU 54 A GLU 55 5 3 3 A SER 162 A SER 163 HELX_P A GLN 167 A GLN 168 1 4 6 A TYR 172 A TYR 173 HELX_P A VAL 176 A VAL 177 5 5 5 A VAL 233 A VAL 234 HELX_P A HIS 235 A HIS 236 5 6 3 A PHE 236 A PHE 237 HELX_P A HIS 243 A HIS 244 1 7 8 disulf 2.031 A CYS 30 A SG CYS 31 1_555 A CYS 46 A SG CYS 47 1_555 disulf 2.018 A CYS 38 A SG CYS 39 1_555 A CYS 109 A SG CYS 110 1_555 disulf 2.021 A CYS 134 A SG CYS 135 1_555 A CYS 203 A SG CYS 204 1_555 disulf 2.031 A CYS 166 A SG CYS 167 1_555 A CYS 182 A SG CYS 183 1_555 disulf 2.030 A CYS 193 A SG CYS 194 1_555 A CYS 221 A SG CYS 222 1_555 HYDROLASE Plasminogen activation, Hydrolase, Serine protease, Glycoprotein, Kringle, EGF-like domain UROK_HUMAN UNP 1 179 P00749 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVEN LILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVK LISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW IRSHT 179 423 1OWJ 1 244 P00749 A 1 1 245 10 7 2 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A GLU 5 A GLU 5 A PHE 6 A PHE 6 A LYS 154 A LYS 155 A ILE 161 A ILE 162 A SER 133 A SER 134 A GLY 138 A GLY 139 A PRO 200 A PRO 201 A LEU 205 A LEU 206 A ARG 208 A ARG 209 A ILE 214 A ILE 215 A PRO 200 A PRO 201 A LEU 205 A LEU 206 A SER 133 A SER 134 A GLY 138 A GLY 139 A LYS 154 A LYS 155 A ILE 161 A ILE 162 A MET 180 A MET 181 A ALA 184 A ALA 185 A GLY 228 A GLY 229 A THR 231 A THR 232 A PHE 15 A PHE 15 A ARG 21 A ARG 21 A VAL 26 A VAL 27 A SER 36 A SER 37 A TRP 39 A TRP 40 A SER 42 A SER 43 A ALA 98 A ALA 99 A ARG 103 A ARG 104 A LYS 74 A LYS 75 A LEU 82 A LEU 83 A TYR 56 A TYR 57 A TYR 59 A TYR 60 A PHE 15 A PHE 15 A ARG 21 A ARG 21 A SER 87 A SER 88 A ALA 88 A ALA 89 A HIS 93 A HIS 94 A HIS 94 A HIS 95 BINDING SITE FOR RESIDUE 155 A 245 Software 11 A HIS 45 A HIS 46 11 1_555 A ASP 49 A ASP 50 11 1_555 A HIS 93 A HIS 94 11 1_555 A ASP 191 A ASP 192 11 1_555 A SER 192 A SER 193 11 1_555 A GLN 194 A GLN 195 11 1_555 A SER 197 A SER 198 11 1_555 A SER 216 A SER 217 11 1_555 A TRP 217 A TRP 218 11 1_555 A GLY 218 A GLY 219 11 1_555 A GLY 220 A GLY 221 11 1_555 19 P 21 21 21